top of page

ACE 031

$300.00Price

Typical Dosing Protocols (Research/Compounded Use Only) – ACE-031

  • Common protocol: 1–3 mg/kg subcutaneously, administered as a single dose or every 2–4 weeks (due to its long half-life). Most users start with 0.5–1 mg/kg and monitor response.

  • Other reported ranges:

    • Standard: 1 mg/kg every 2–4 weeks

    • Clinical/exploratory: Up to 3 mg/kg as a single dose or repeated every 2–4 weeks

    • Cycle length: Short or infrequent cycles (typically 4–12 weeks total exposure) due to potency and duration of action.

  • Reconstitution example (for research vials, commonly 1 mg or larger): Add sterile water (some prefer non-bacteriostatic for protein stability).

    • Dosage volume depends on concentration after reconstitution (gentle mixing recommended).

  • Administration: Subcutaneous injection. Due to the long half-life, frequent daily injections are not required.

Dosing is highly individualized based on goals (muscle growth, body composition) and response—consult a qualified healthcare provider experienced with peptides for personalized guidance. This is for informational purposes only.

bottom of page